Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years with the drugmaker, seven years as executive vice president of ...

Novo Nordisk (NVO) executive Camilla Sylvest is departing the drugmaker after 28 years, Bloomberg’s Sara Sjolin reports. Sylvest has served as executive vice president for commercial strategy ...

After a distinguished career of 28 years with Novo Nordisk, hereof seven years as executive vice president of Commercial Strategy & Corporate Affairs, Camilla Sylvest has decided to leave the company.

Camilla Sylvest har tilbragt hele sin karriere i Novo Nordisk, hvor hun har arbejdet sig til tops. Hun har dog aldrig haft et mål om at havne på den øverste hylde, for hendes ambitioner har altid ...

Camilla Sylvest, Novo Nordisk's head of commercial strategy and corporate affairs, said at the company's Capital Markets Day yesterday that the company expects to meet demand for Wegovy in the US ...

Camilla Sylvest, Novo Nordisk executive vice president, commercial strategy and corporate affairs, said: "We are passionate about improving the lives of people with obesity and finding new ...

LONDON/COPENHAGEN (Reuters) - Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday.

LONDON/COPENHAGEN (Reuters) - Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday. Novo's rare ...